Holen Sie sich die Stockscreener-App
17.80
0.28%
0.05
Handel nachbörslich:
17.77
-0.03
-0.17%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt KVUE?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$17.75
Offen:
$17.76
24-Stunden-Volumen:
43.89M
Relative Volume:
1.06
Marktkapitalisierung:
$34.10B
Einnahmen:
$15.01B
Nettoeinkommen (Verlust:
$1.43B
KGV:
23.92
EPS:
0.744
Netto-Cashflow:
$1.63B
1W Leistung:
+3.49%
1M Leistung:
+4.58%
6M Leistung:
-21.03%
1J Leistung:
-14.22%
1-Tages-Spanne:
$17.65
$17.83
1-Wochen-Bereich:
$16.99
$17.83
52-Wochen-Spanne:
$14.02
$25.17
Kenvue Inc Stock (KVUE) Company Profile
Firmenname
Kenvue Inc
Sektor
Telefon
908-874-1200
Adresse
1 KENVUE WAY, SUMMIT
Vergleichen Sie KVUE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KVUE
Kenvue Inc
|
17.80 | 34.01B | 15.01B | 1.43B | 1.63B | 0.744 |
|
PG
Procter Gamble Co
|
150.15 | 350.35B | 85.26B | 16.53B | 14.85B | 6.7488 |
|
UL
Unilever Plc Adr
|
67.00 | 142.90B | 64.99B | 6.71B | 6.53B | 2.74 |
|
CL
Colgate Palmolive Co
|
86.66 | 69.17B | 20.10B | 3.04B | 3.44B | 3.569 |
|
EL
Estee Lauder Cos Inc
|
117.69 | 43.06B | 14.42B | -930.00M | 1.05B | -2.5832 |
Kenvue Inc Stock (KVUE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-29 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2025-09-26 | Hochstufung | Rothschild & Co Redburn | Neutral → Buy |
| 2025-04-10 | Eingeleitet | Redburn Atlantic | Neutral |
| 2025-03-24 | Eingeleitet | Evercore ISI | In-line |
| 2025-01-06 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-12 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2024-09-24 | Eingeleitet | Jefferies | Buy |
| 2024-09-24 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-05-28 | Fortgesetzt | Citigroup | Neutral |
| 2024-04-11 | Eingeleitet | Bernstein | Underperform |
| 2024-04-03 | Eingeleitet | William Blair | Mkt Perform |
| 2024-03-01 | Fortgesetzt | Goldman | Neutral |
| 2023-11-17 | Eingeleitet | Piper Sandler | Neutral |
| 2023-09-11 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2023-09-07 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-09-06 | Eingeleitet | Argus | Hold |
| 2023-08-24 | Hochstufung | Goldman | Neutral → Buy |
| 2023-07-25 | Eingeleitet | Edward Jones | Buy |
| 2023-06-01 | Eingeleitet | HSBC Securities | Hold |
| 2023-05-30 | Eingeleitet | BofA Securities | Buy |
| 2023-05-30 | Eingeleitet | Citigroup | Neutral |
| 2023-05-30 | Eingeleitet | Deutsche Bank | Hold |
| 2023-05-30 | Eingeleitet | Exane BNP Paribas | Neutral |
| 2023-05-30 | Eingeleitet | Goldman | Neutral |
| 2023-05-30 | Eingeleitet | JP Morgan | Overweight |
| 2023-05-30 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-05-30 | Eingeleitet | UBS | Neutral |
Alle ansehen
Kenvue Inc Aktie (KVUE) Neueste Nachrichten
Kenvue Inc. $KVUE Shares Sold by Wealth Enhancement Advisory Services LLC - MarketBeat
Kenvue stock steadies near $18 as investors eye Jan. 29 merger vote — here’s what matters next week - TechStock²
Kenvue Inc. $KVUE Shares Sold by UniSuper Management Pty Ltd - MarketBeat
483,928 Shares in Kenvue Inc. $KVUE Purchased by Y Intercept Hong Kong Ltd - MarketBeat
Analysts Offer Insights on Consumer Goods Companies: Kenvue, Inc. (KVUE) and Primo Brands (PRMB) - The Globe and Mail
Kenvue Unit Asks Justices To Clarify Class Cert. Expert Rules - Law360
The New York Stock Exchange | NYSE - NYSE
Kenvue (KVUE) stock price barely budges as Kimberly-Clark deal vote nears - TechStock²
Kenvue stock rating reiterated at Sector Perform by RBC Capital - Investing.com Canada
RBC Capital Maintains Kenvue(KVUE.US) With Hold Rating, Maintains Target Price $21 - 富途资讯
Kenvue stock rating reiterated at Sector Perform by RBC Capital By Investing.com - Investing.com Australia
Assessing Kenvue (KVUE) After Its Separation From Johnson & Johnson - Yahoo Finance
ISS Backs Kimberly-Clark Kenvue Deal As Valuation Signals Undervaluation - Sahm
Kenvue stock price jumps 2% as KVUE takeover vote nears — what traders watch next - TechStock²
Kenvue stock price rebounds as merger vote nears — what KVUE traders watch next - TechStock²
Kenvue Introduces ORSL For Diarrheal And eRZL For Daily Hydration - SMEStreet
Allstate Corp Makes New Investment in Kenvue Inc. $KVUE - MarketBeat
Johnson & Johnson: Defensive Strength, Disciplined Growth, and Long-Term Value - Investing.com
Consumer health firm Kenvue announces dual brand strategy with two hydration solutions - ET HealthWorld
Kenvue stock price slips as Kimberly-Clark drops, deal vote stays in focus - TechStock²
ISS Backs Kenvue (KVUE) Deal, Investors Debate Tylenol and Litigation Risks - Finviz
Kenvue bets on dual‑brand push to dominate India’s fast‑growing hydration market - Moneycontrol
Kenvue differentiates its ORS brand from its electrolyte drink - BusinessLine
Kenvue stock steadies as Kimberly-Clark deal vote nears, with lawsuits in the mix - TechStock²
Vest Financial LLC Grows Stock Position in Kenvue Inc. $KVUE - MarketBeat
ISS backs Kenvue (KVUE) deal, investors debate Tylenol and litigation risks - MSN
ISS recommends shareholders approve Kimberly-Clark's planned Kenvue deal - MSN
The New Titan of Wellness: Kimberly-Clark’s $48.7 Billion Kenvue Acquisition Reshapes Consumer Staples - The Chronicle-Journal
Kenvue stock ticks up as investors size up Kimberly-Clark takeover vote in days - TechStock²
Activist investors do not plan to play nice this year as they eye more corporate breakups - marketscreener.com
Analysts Offer Insights on Consumer Goods Companies: Kenvue, Inc. (KVUE) and McCormick & Company (MKC) - The Globe and Mail
A Look Into Kenvue Inc's Price Over Earnings - Benzinga
Is Johnson & Johnson A Dividend Stock, Or Something Else? (NYSE:JNJ) - Seeking Alpha
Massachusetts Financial Services Co. MA Sells 3,862,828 Shares of Kenvue Inc. $KVUE - MarketBeat
Published on: 2026-01-19 01:22:15 - baoquankhu1.vn
Portfolio Recap: Can Kenvue Inc weather a recession2025 Investor Takeaways & Short-Term Swing Trade Alerts - baoquankhu1.vn
Kenvue stock has a new catalyst: ISS backs Kimberly-Clark merger ahead of Jan. 29 vote - TechStock²
Tylenol Pregnancy Study Contradicts Trump Claims on Autism Link - Bloomberg.com
Kenvue's Study Finds No Autism Link with Acetaminophen Use During Pregnancy - Intellectia AI
No link between autism and Tylenol: new study (KVUE:NYSE) - Seeking Alpha
Kenvue stock: ISS backs Kimberly-Clark deal as lawsuit filings add pressure ahead of vote - TechStock²
Kenvue Inc. $KVUE Shares Sold by SG Americas Securities LLC - MarketBeat
Kenvue Inc. $KVUE Shares Purchased by Arlington Partners LLC - MarketBeat
Tylenol pregnancy study contradicts Trump's claims on link with autism - Business Standard
Kenvue Supplements Proxy Disclosures Ahead of Merger Vote - TipRanks
KIMBERLY CLARK CORP Announces Merger with Kenvue - TradingView
KMB SEC FilingsKimberly-Clark Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Lobbying Update: $60,000 of KENVUE INC. lobbying was just disclosed - Quiver Quantitative
ISS Recommends Approval of Kimberly-Clark's $49B Kenvue Acquisition - Intellectia AI
ISS recommends shareholders approve Kimberly-Clark's planned Kenvue deal | Business Information & News | FE - Westlaw Today
ISS recommends shareholders approve Kimberly-Clark’s planned Kenvue deal - 93.3 The Drive
Finanzdaten der Kenvue Inc-Aktie (KVUE)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.04%
1.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):